the WHITE HOUSEPresident Donald J. Trump

Search form

President’s Commission on Combating Drug Addiction and the Opioid Crisis

On March 29, 2017, President Donald J. Trump signed an Executive Order establishing the President’s Commission on Combating Drug Addiction and the Opioid Crisis. The Commission will be chaired by Governor Chris Christie and will study ways to combat and treat the scourge of drug abuse, addiction, and the opioid crisis, which was responsible for more than 50,000 deaths in 2015 and has caused families and communities across America to endure significant pain and suffering. The Commission will work closely with the White House Office of American Innovation led by Jared Kushner.

President Trump said, “I made a promise to the American people to take action to keep drugs from pouring into our country and to help those who have been so badly affected by them. Governor Christie will be instrumental in researching how best to combat this serious epidemic and how to treat those it has affected. He will work with people on both sides of the aisle to find the best ways for the Federal Government to treat and protect the American people from this serious problem. This is an epidemic that knows no boundaries and shows no mercy, and we will show great compassion and resolve as we work together on this important issue.”

The Office of National Drug Control Policy (ONDCP) provides administrative and financial support for the Commission and its activities.


The mission of the Commission shall be to study the scope and effectiveness of the Federal response to drug addiction and the opioid crisis and to make recommendations to the President for improving that response.  The Commission shall:

(a)  identify and describe existing Federal funding used to combat drug addiction and the opioid crisis;

(b)  assess the availability and accessibility of drug addiction treatment services and overdose reversal throughout the country and identify areas that are underserved;

(c)  identify and report on best practices for addiction prevention, including healthcare provider education and evaluation of prescription practices, and the use and effectiveness of State prescription drug monitoring programs;

(d)  review the literature evaluating the effectiveness of educational messages for youth and adults with respect to prescription and illicit opioids;

(e)  identify and evaluate existing Federal programs to prevent and treat drug addiction for their scope and effectiveness, and make recommendations for improving these programs; and

(f)  make recommendations to the President for improving the Federal response to drug addiction and the opioid crisis.


Please check back soon for updates regarding the Commission and its upcoming meetings.